论文部分内容阅读
随着弱视发病机理的深入研究，有关弱视治疗已经从传统的遮盖疗法中发展出一些新的疗法。1990年有人首次报告单剂量左族多巴可改善弱视，以后有人对主旋多巴治疗弱视进行了系统的药物动力学、安全性、耐受性等基础及临床研究。结果表明0．55mg／kg左旋多巴和25％卡比多巴，每日3次，可以治疗弱视，并且不产生明显的副作用，可望成为弱视治疗的最有价值的疗法，一改弱视治疗二百年不变的传统遮盖疗法。
With the in-depth study of the pathogenesis of amblyopia, the amblyopia treatment has developed some new therapies from the traditional cover therapies. It was first reported in 1990, a single dose of left dopa can improve amblyopia, atropine treatment of amblyopia after a systematic pharmacokinetics, safety, tolerance and other basic and clinical research. The results showed that 0.55mg / kg levodopa and 25% carbidopa, 3 times a day, can treat amblyopia, and did not produce significant side effects, is expected to be the most valuable treatment for amblyopia, changed amblyopia treatment Two hundred years of traditional cover therapy.